634587-38-5

Basic information

• Product Name: Carbamic acid, [(1S,2S,3R)-2,3-dihydroxy-1-(hydroxymethyl)heptadecyl]-, phenylmethyl ester
• CAS NO: 634587-38-5
• Molecular Formula: C26H45NO5
• Molecular Weight: 451.647
• Mol File: 634587-38-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(1S,2S,3R)-2,3-dihydroxy-1-(hydroxymethyl)heptadecyl]-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1S,2S,3R)-2,3-dihydroxy-1-(hydroxymethyl)heptadecyl]-, phenylmethyl ester(634587-38-5)
• EPA Substance Registry System: Carbamic acid, [(1S,2S,3R)-2,3-dihydroxy-1-(hydroxymethyl)heptadecyl]-, phenylmethyl ester(634587-38-5)

Safety Data

• Hazardous Substances Data: 634587-38-5(Hazardous Substances Data)

Upstream product

• 554-62-1 D-ribo-phytosphingosine 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 634587-40-9 (2S,3R,4R)-1-O-tert-butyldimethysilyl-2-benzyloxycarbonylamino-1,3,4-octadecanetriol 
• 1607008-37-6 C₅₈H₈₀N₂O₁₀ 
• 634587-42-1 (2S,3R,4R)-1-O-tert-butyldimethysilyl-2-benzyloxycarbonylamino-3,4-di-O-isopropylidene-1,3,4-octadecanetriol 
• 634587-44-3 (2S,3S,4R)-2-benzyloxycarbonylamino-3,4-di-O-isopropy-lidene-1,3,4-octadecanetriol 
• 799267-95-1 [(S)-1-((4S,5R)-2,2-Dimethyl-5-tetradecyl-[1,3]dioxolan-4-yl)-allyl]-carbamic acid benzyl ester 

Relevant articles and documents

Efficient synthesis of α-C-galactosyl ceramide immunostimulants: Use of ethylene-promoted olefin cross-metathesis

(Chemical Equation Presented) Olefin cross-metathesis has been used to prepare α-C-galactosylceramide derivatives. The metathesis process merged vinyl and propenyl glycosides with vinyl derivatives of phytosphingosine. The use of ethylene enhanced the yie

METHOD OF PREPARATION OF α-GALACTOSYL CERAMIDES COMPOUNDS

The present invention relates to a method of preparation of α-galactosyl ceramides compounds of formula (I) comprising a step a) of glycosylation of a compound of formula (II) with a compound of formula (III).

SYNTHETIC C-GLYCOLIPID AND ITS USE FOR TREATING CANCER INFECTIOUS DISEASES AND AUTOIMMUNE DISEASES

The invention is directed to compounds of formula (I) wherein X is O, OR NH; R' is a hydrocarbon chain; R and are hydrogen, OH or a monosaccharide; R is hydrogen or a monosaccharide; Q' is optionally present and may be a C1-10 hydrocarbon; X' i